Results 11 to 20 of about 238,371 (341)

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure
Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH.
Oliver Dörr, Stanislav Keranov, Paulina vanWickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
doaj   +2 more sources

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction [PDF]

ESC Heart Failure, 2018
Background Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome that presents clinicians with a diagnostic challenge. The use of natriuretic peptides to exclude a diagnosis of HFpEF has been proposed.
Abbate, Antonio, Arena, Ross, Billingsley, Hayley, Buckley, Leo F., Canada, Justin M., Carbone, Salvatore, Del Buono, Marco G., Kadariya, Dinesh, Trankle, Cory R., Van Tassell, Benjamin W.   +9 more
core   +3 more sources

Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC

European Journal of Heart Failure, 2023
Diagnosing heart failure is often difficult due to the non‐specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure.
Antoni Bayés-Genís, Kieran F Doherty, Mark C. Petrie, J. Januzzi, C. Mueller, Lisa Andreson, B. Bozkurt, J. Butler, O. Chioncel, J. Cleland, R. Christodorescu, Stefano Del Prato, F. Gustafsson, Carolyn S. P. Lam, B. Moura, R. Pop-Busui, Petar M Seferović, M. Volterrani, M. Vaduganathan, M. Metra, Giuseppe M C Rosano   +20 more
semanticscholar   +1 more source

Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort

Circulation: Heart Failure, 2022
Background: Demographic differences in expected NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration are not well established. We aimed to establish reference ranges for NT-proBNP and explore the determinants of moderately elevated NT ...
P. Welsh, R. Campbell, Leanne Mooney, D. Kimenai, C. Hayward, A. Campbell, D. Porteous, N. Mills, N. Lang, M. Petrie, J. Januzzi, J. McMurray, N. Sattar   +12 more
semanticscholar   +1 more source

NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis

International Journal of COPD, 2023
Purpose NT-proBNP, a peptide biomarker synthesized and secreted by cardiomyocytes in response to cardiac load, has gained attention in recent years for its potential role in respiratory diseases.
Xiaojie Su, Ting Lei, Haichuan Yu, Lu-Miao Zhang, Zhouzhou Feng, Tian-kui Shuai, Hong Guo, Jian Liu   +7 more
semanticscholar   +1 more source

NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial.

European Heart Journal, 2023
BACKGROUND AND AIMS STRONG-HF showed that rapid up-titration of guideline-recommended medical therapy (GRMT), in a high intensity care (HIC) strategy, was associated with better outcomes compared to usual care (UC).
M. Adamo, M. Pagnesi, A. Mebazaa, B. Davison, C. Edwards, D. Tomasoni, M. Arrigo, M. Barros, J. Biegus, J. Čelutkienė, Kamilė Čerlinskaitė-Bajorė, O. Chioncel, A. Cohen-Solal, A. Damasceno, R. Díaz, G. Filippatos, E. Gayat, A. Kimmoun, C. Lam, Maria Novosadova, P. Pang, P. Ponikowski, H. Saidu, K. Sliwa, K. Takagi, J. T. ter Maaten, A. Voors, G. Cotter, M. Metra   +28 more
semanticscholar   +1 more source

Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

Circulation: Heart Failure, 2023
Background: NT-proBNP (N-terminal pro-B-type natriuretic peptide) is a potent predictor of death and heart failure (HF) across multiple populations. We evaluated the prognostic importance of NT-proBNP in patients with acute myocardial infarction (MI ...
K. Jering, B. Claggett, M. Pfeffer, C. Granger, L. Køber, E. Lewis, A. Maggioni, D. Mann, J. McMurray, M. Prescott, J. Rouleau, S. Solomon, P. Steg, D. von Lewinski, E. Braunwald   +14 more
semanticscholar   +1 more source

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023
Background NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) is strongly associated with mortality in patients with heart failure. Prior studies, primarily in middle‐aged and older populations, have suggested that NT‐proBNP has prognostic value in ...
J. Echouffo-Tcheugui, Sui Zhang, N. Daya, J. McEvoy, Olive Tang, S. Juraschek, C. Ndumele, J. Coresh, R. Christenson, E. Selvin   +9 more
semanticscholar   +1 more source

Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study)

Pediatric Cardiology, 2022
This study aimed to provide reliable pediatric reference values for N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitive Troponin T (hsTnT) obtained from a population of well children and investigate for associations with sex, pubertal
A. Kiess, J. Green, A. Willenberg, U. Ceglarek, I. Dähnert, A. Jurkutat, A. Körner, A. Hiemisch, W. Kiess, M. Vogel   +9 more
semanticscholar   +1 more source

Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

JACC. Heart failure, 2022
BACKGROUND N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used for diagnostic and prognostic evaluation in heart failure (HF). Previous clinical trials in heart failure with mildly reduced ejection fraction (HFmrEF) or heart failure with ...
P. Myhre, M. Vaduganathan, B. Claggett, Z. Miao, P. Jhund, Rudolf A. de Boer, A. Hernandez, S. Inzucchi, M. Kosiborod, C. Lam, F. Martinez, Sanjiv J. Shah, Akshay S. Desai, D. Lindholm, Magnus Petersson, A. Langkilde, J. McMurray, S. Solomon   +17 more
semanticscholar   +1 more source